Massive bullous local reaction following administration of Ad26.COV2.S COVID-19 vaccine.

Montero-Menárguez, Julia; Falkenhain-López, Daniel; Guzmán-Pérez, Luisa María; Rodríguez-Peralto, José Luis; Tous-Romero, Fátima; Gallego-Álvarez, Silvia

Montero-Menárguez, Julia; Falkenhain-López, Daniel; Guzmán-Pérez, Luisa María; Rodríguez-Peralto, José Luis; Tous-Romero, Fátima; Gallego-Álvarez, Silvia.

Montero-Menárguez J; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Falkenhain-López D; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Guzmán-Pérez LM; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Rodríguez-Peralto JL; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Tous-Romero F; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Gallego-Álvarez S; Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.

Int J Dermatol ; 61(5): 636-638, 2022 05.

Article in English | MEDLINE | ID: covidwho-1635605

Subject(s)

Ad26COVS1; COVID-19; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Ad26COVS1 Topics: Vaccines Limits: Humans Language: English Journal: Int J Dermatol Year: 2022 Document Type: Article Affiliation country: Ijd.16037

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google